Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises DORO SAS in connection with the acquisition of all shares in French based Prylos SAS
Mandate

Vinge advises DORO SAS in connection with the acquisition of all shares in French based Prylos SAS

July 12, 2011

Vinge has advised DORO SAS in connection with its acquisition of all shares in the French based company, Prylos SAS. DORO SAS is a wholly-owned subsidiary of DORO AB, the shares of which are listed on the Nordic List, Small Companies, on OMX NASDAQ Stockholm. Doro focuses on the development, marketing and sale of telecom products which are specifically directed to the elderly. With more than 35 years experience and sales in more than 30 countries on five continents, Doro is a world leading trademark within the field of simple and user-friendly mobile phones. As a result of the acquisition, Doro has acquired an Android-based platform for its product launches and a dedicated development team within telecom solutions for senior citizens.

Vinge’s team advising DORO SAS consisted of partners Johan Winnerblad and Johan Göthberg and associate Nina Farrahi. Partner Karin Grauers provided intellectual property law advice.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025